In August 2017, CMBG3 Law reported that a California jury returned a verdict against Johnson & Johnson in the amount of $417 million, ending the first California case tried to verdict against Johnson & Johnson in which it was alleged that the company’s talcum...
CMBG3 Law reported last week that the first asbestos-contaminated talcum powder trial in California began trial, but was cut short two days into the trial as the judge declared a mistrial. This week, a new jury was seated and trial began yesterday. In the case,...
In February of 2016, a St. Louis jury returned a verdict in favor of plaintiff Jacqueline Fox for $72 million. In the case, plaintiff alleged that she developed ovarian cancer from Johnson & Johnson’s talcum powder products. Johnson & Johnson appealed the...
CMBG3 Law previously reported on a verdict against Johnson & Johnson out of California in the amount of $417 million, which was the first California case tried to verdict against Johnson & Johnson in which it was alleged that the company’s talcum powder...
CMBG3 Law reported yesterday on the start of the first asbestos-contaminated talcum powder trial in California. Later in the day, the Judge declared a mistrial and so a new jury will be picked and the trial will resume at a date to be determined. The reason for the...
CMBG3 Law has reported throughout the year on events in the pending talcum powder litigation, in which plaintiffs allege that talcum powder caused their ovarian or uterine cancer. Although the ovarian and uterine cancer cases have dominated the news, most recently in...
On September 25, 2017, two prominent plaintiffs' experts (Sean Fitzgerald, Geologist and Dr. Ronald Gordon, MD) were excluded from testifying in the asbestos case of Sally Brandt and Charles Brandt v. The Bon-Ton Stores, Inc., et al., Court of common Pleas of...
In June of 2017, the United States Supreme Court issued two rulings, both of which addressed whether plaintiffs can bring lawsuits in states in which the plaintiffs and defendants have little or no connection. The Supreme Court’s rulings made it clear that in cases...
New Jersey was one of the first states to establish a multidistrict litigation (MDL) docket for thousands of pending ovarian and uterine cancer claims against Johnson & Johnson for the company’s talcum powder products. Last week, a number of plaintiffs on the New...
Johnson & Johnson’s motion to delay trial in hundreds of talc-based ovarian cancer cases pending in the 22nd Circuit Court of Missouri was recently denied by appellate Judge Angela T. Quigless. Johnson & Johnson, manufacturer and marketer of numerous...